What is LOPJLB’s current signal on ALDX?

LOPJLB’s latest quantitative signal on Aldeyra The (ALDX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ALDX in?

Aldeyra The (ALDX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Aldeyra The (ALDX) do?

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of prima…

Where is Aldeyra The based / listed?

Aldeyra The is based in US, listed on NASDAQ.

Aldeyra The (ALDX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.92-3.16%Close

SELLCRISIS · day 12

[SCORES & PROFILE]

FUND: 14
VALUE: 14
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-31.9%

REV YoY-

ROE-53.1%

EPS YoY-

ROA-48.5%

GROSS

NET

[VALUATION]

P/E TTM-2.37

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B1.46

P/FCF-

EV/EBITDA-0.48

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.38

ALTMAN Z-

CURR RATIO4.91

ND/EBITDA-

BETA1.20

Aldeyra The (ALDX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news